Table 8.

Factors associated with quality of life of patients with breast cancer at Khartoum Oncology Hospital

Variables	QLQ-C30-Functional scales
	S.E	Sig	OR	95% CI
Age	0.94	0.135	0.25	0.04–1.55
Comorbidity	0.44	0.355	0.67	0.28–1.58
Medications (ref. conventional therapy)
Hormonal therapy	0.53	0.01**	3.74	1.32–10.63
Targeted therapy	1.13	0.04*	10.2	1.11–93.88
Stage of tumor (ref. stage 1)
Stage 2	0.73	0.13	0.33	0.08–1.39
Stage 3	0.41	0.26	0.64	0.29–1.41
Cycle of chemotherapy	0.41	0.36	0.69	0.31–1.54
	QLQ-C30-Symptom scales
Age	1.01	0.516	1.921	0.27–13.79
Comorbidity	0.46	0.863	0.924	0.38–2.26
Medications (ref. conventional therapy)
Hormonal therapy	0.67	0.000***	0.07	0.02–0.29
Targeted therapy	0.86	0.08	0.22	0.04–1.25
Stage of tumor (ref. stage 1)
Stage 2	0.85	0.14	3.52	0.67–18.61
Stage 3	0.39	0.76	1.13	0.53–2.42
Cycle of chemotherapy	0.40	0.87	0.94	0.43–2.05

S.E Standard error, OR Odd ratio, CI Confidence interval

^*P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001